Literature DB >> 33641005

Treatment personalization in gastrointestinal neuroendocrine tumors.

Chiara Borga1, Gianluca Businello1, Sabina Murgioni2, Francesca Bergamo2, Chiara Martini3, Eugenio De Carlo3, Elisabetta Trevellin3, Roberto Vettor3, Matteo Fassan4.   

Abstract

OPINION STATEMENT: The clinical scenario of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) is continuously changing due to significant improvements in the definition of their molecular landscapes and the introduction of innovative therapeutic approaches. Many efforts are currently employed in the integration of the genetics/epigenetics and clinical information. This is leading to an improvement of tumor classification, prognostic stratification and ameliorating the management of patients based on a personalized approach.

Entities:  

Keywords:  GEP-NENs; Immunotherapy; NETs; PRRT; SSAs; Targeted therapies

Mesh：

Substances：

Year:  2021        PMID： 33641005     DOI： 10.1007/s11864-021-00825-4

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN： 1534-6277


  95 in total

1.  Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors.

Authors:  Shinichi Yachida; Efsevia Vakiani; Catherine M White; Yi Zhong; Tyler Saunders; Richard Morgan; Roeland F de Wilde; Anirban Maitra; Jessica Hicks; Angelo M Demarzo; Chanjuan Shi; Rajni Sharma; Daniel Laheru; Barish H Edil; Christopher L Wolfgang; Richard D Schulick; Ralph H Hruban; Laura H Tang; David S Klimstra; Christine A Iacobuzio-Donahue
Journal:  Am J Surg Pathol       Date:  2012-02       Impact factor: 6.394

Review 2.  Well-differentiated pancreatic neuroendocrine tumours (PanNETs) and poorly differentiated pancreatic neuroendocrine carcinomas (PanNECs): concepts, issues and a practical diagnostic approach to high-grade (G3) cases.

Authors:  Aatur D Singhi; David S Klimstra
Journal:  Histopathology       Date:  2018-01       Impact factor: 5.087

3.  Unmet Needs in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3).

Authors:  Halfdan Sorbye; Eric Baudin; Ivan Borbath; Martyn Caplin; Jie Chen; Jaroslaw B Cwikla; Andrea Frilling; Ashley Grossman; Gregory Kaltsas; Aldo Scarpa; Staffan Welin; Rocio Garcia-Carbonero
Journal:  Neuroendocrinology       Date:  2018-08-28       Impact factor: 4.914

Review 4.  Gastroenteropancreatic Neuroendocrine Tumors.

Authors:  Mauro Cives; Jonathan R Strosberg
Journal:  CA Cancer J Clin       Date:  2018-10-08       Impact factor: 508.702

Review 5.  The 2010 WHO classification of digestive neuroendocrine neoplasms: a critical appraisal four years after its introduction.

Authors:  G Rindi; G Petrone; F Inzani
Journal:  Endocr Pathol       Date:  2014-06       Impact factor: 3.943

6.  Therapeutic Options for Neuroendocrine Tumors: A Systematic Review and Network Meta-analysis.

Authors:  Reto M Kaderli; Marko Spanjol; Attila Kollár; Lukas Bütikofer; Viktoria Gloy; Rebecca A Dumont; Christian A Seiler; Emanuel R Christ; Piotr Radojewski; Matthias Briel; Martin A Walter
Journal:  JAMA Oncol       Date:  2019-04-01       Impact factor: 31.777

Review 7.  Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas.

Authors:  Bryan Oronsky; Patrick C Ma; Daniel Morgensztern; Corey A Carter
Journal:  Neoplasia       Date:  2017-11-05       Impact factor: 5.715

Review 8.  Current best practice in the management of neuroendocrine tumors.

Authors:  Marina Tsoli; Eleftherios Chatzellis; Anna Koumarianou; Dionysia Kolomodi; Gregory Kaltsas
Journal:  Ther Adv Endocrinol Metab       Date:  2018-10-31       Impact factor: 3.565

Review 9.  Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms.

Authors:  Andrea Mafficini; Aldo Scarpa
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

10.  A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal.

Authors:  Guido Rindi; David S Klimstra; Behnoush Abedi-Ardekani; Sylvia L Asa; Frederik T Bosman; Elisabeth Brambilla; Klaus J Busam; Ronald R de Krijger; Manfred Dietel; Adel K El-Naggar; Lynnette Fernandez-Cuesta; Günter Klöppel; W Glenn McCluggage; Holger Moch; Hiroko Ohgaki; Emad A Rakha; Nicholas S Reed; Brian A Rous; Hironobu Sasano; Aldo Scarpa; Jean-Yves Scoazec; William D Travis; Giovanni Tallini; Jacqueline Trouillas; J Han van Krieken; Ian A Cree
Journal:  Mod Pathol       Date:  2018-08-23       Impact factor: 7.842
View more
  5 in total

1.  Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy.

Authors:  Fabrice Viol; Bence Sipos; Martina Fahl; Till S Clauditz; Tania Amin; Malte Kriegs; Maike Nieser; Jakob R Izbicki; Samuel Huber; Ansgar W Lohse; Jörg Schrader
Journal:  Cell Oncol (Dordr)       Date:  2022-10-21       Impact factor: 7.051

Review 2.  New insights in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Feng Yin; Zi-Hao Wu; Jin-Ping Lai
Journal:  World J Gastroenterol       Date:  2022-05-07       Impact factor: 5.374

3.  Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours.

Authors:  Karen Rico; Suzann Duan; Ritu L Pandey; Yuliang Chen; Jayati T Chakrabarti; Julie Starr; Yana Zavros; Tobias Else; Bryson W Katona; David C Metz; Juanita L Merchant
Journal:  BMJ Open Gastroenterol       Date:  2021-11

Review 4.  Update on Epidemiology, Diagnosis, and Biomarkers in Gastroenteropancreatic Neuroendocrine Neoplasms.

Authors:  Daisuke Takayanagi; Hourin Cho; Erika Machida; Atsushi Kawamura; Atsuo Takashima; Satoshi Wada; Takuya Tsunoda; Takashi Kohno; Kouya Shiraishi
Journal:  Cancers (Basel)       Date:  2022-02-22       Impact factor: 6.639

5.  The Effect of Different Nutritional Nursing Support on the Nutritional Status and Disease Recovery of Elderly Patients with Gastrointestinal Tumors during the Perioperative Period.

Authors:  Lingzhi Chen; Sixin Zheng; Qi Xie; Liping Huang; Guang Yin
Journal:  Comput Math Methods Med       Date:  2022-06-29       Impact factor: 2.809
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.